Interact to see
Advertisement
Advertisement
CURE vs SSO
CURE vs SSO Comparison Chart in %
Loading...
Show more...
Show more...
View a ticker or compare two or three
VS
VS
CURE vs. SSO commentary
Jul 06, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CURE is a Buy and SSO is a Buy.
SUMMARIES
FUNDAMENTALS
Fundamentals
SSO has more net assets: 6.55B vs. CURE (136M). SSO has a higher annual dividend yield than CURE: SSO (8.471) vs CURE (-12.980). CURE was incepted earlier than SSO: CURE (14 years) vs SSO (19 years). SSO (0.89) and CURE (0.93) have comparable expense ratios . CURE has a higher turnover SSO (4.00) vs SSO (4.00).
| CURE | SSO | CURE / SSO | |
| Gain YTD | -12.980 | 8.471 | -153% |
| Net Assets | 136M | 6.55B | 2% |
| Total Expense Ratio | 0.93 | 0.89 | 104% |
| Turnover | 23.00 | 4.00 | 575% |
| Yield | 1.40 | 0.81 | 173% |
| Fund Existence | 14 years | 19 years | - |
TECHNICAL ANALYSIS
Technical Analysis
| CURE | SSO | |
|---|---|---|
| RSI ODDS (%) | N/A | 4 days ago 90% |
| Stochastic ODDS (%) | 4 days ago 90% | 4 days ago 82% |
| Momentum ODDS (%) | 4 days ago 84% | 4 days ago 90% |
| MACD ODDS (%) | N/A | 4 days ago 90% |
| TrendWeek ODDS (%) | 4 days ago 90% | 4 days ago 90% |
| TrendMonth ODDS (%) | 4 days ago 90% | 4 days ago 90% |
| Advances ODDS (%) | 11 days ago 90% | 4 days ago 90% |
| Declines ODDS (%) | 17 days ago 90% | 17 days ago 84% |
| BollingerBands ODDS (%) | 4 days ago 86% | 4 days ago 79% |
| Aroon ODDS (%) | 4 days ago 90% | 4 days ago 90% |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
Show more...
Show more...
Interesting Tickers
CURE and
Correlation & Price change
A.I.dvisor indicates that over the last year, CURE has been loosely correlated with IQV. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if CURE jumps, then IQV could also see price increases.
1D
1W
1M
1Q
6M
1Y
5Y
| Ticker / NAME | Correlation To CURE | 1D Price Change % | ||
|---|---|---|---|---|
| CURE | 100% | N/A | ||
| IQV - CURE | 65% Loosely correlated | -0.25% | ||
| GEHC - CURE | 63% Loosely correlated | -0.07% | ||
| TMO - CURE | 59% Loosely correlated | +0.37% | ||
| MRK - CURE | 57% Loosely correlated | -1.77% | ||
| JNJ - CURE | 56% Loosely correlated | +0.29% | ||
More | ||||
SSO and
Correlation & Price change
A.I.dvisor indicates that over the last year, SSO has been loosely correlated with MSFT. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if SSO jumps, then MSFT could also see price increases.
1D
1W
1M
1Q
6M
1Y
5Y
| Ticker / NAME | Correlation To SSO | 1D Price Change % | ||
|---|---|---|---|---|
| SSO | 100% | +1.49% | ||
| MSFT - SSO | 63% Loosely correlated | +1.58% | ||
| AAPL - SSO | 62% Loosely correlated | +0.52% | ||
| AMZN - SSO | 60% Loosely correlated | +1.59% | ||
| NVDA - SSO | 56% Loosely correlated | +1.33% |